Protagenic therapeutics announces date of annual shareholder meeting

New york, ny / accesswire / october 13, 2023 / protagenic therapeutics, inc. (nasdaq:ptix) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced its fy 2022 annual shareholder meeting will be held wednesday, december 13, 2023, at 10:00 am est, for shareholders of record as of this coming monday, october 16th. those who would like to attend the meeting virtually may do so by going to the website www.virtualshareholdermeeting.com/ptix2023.
PTIX Ratings Summary
PTIX Quant Ranking